Features

Industry: More Clarity, More Time Needed on PMD Policies

Atlanta With a number of new mobility policies set to take effect within the next year, many HME stakeholders say CMS should slow down and make some major

Atlanta

With a number of new mobility policies set to take effect within the next year, many HME stakeholders say CMS should slow down and make some major revisions before moving forward.

More than 500 callers jammed the phone lines and 45 to 55 appeared in person last month at a three-hour Open Door session, which focused on the interim final rule that eliminates the power mobility CMN.

Implementation of the rule should be delayed until at least April 1, 2006, according to Dan Meuser, president of Exeter, Pa.-based Pride USA. “Folks, providers cannot adapt to this rapid change in this time period,” Meuser told CMS officials at the session, citing provider concerns about retooling billing systems to the new requirements, concerns the DMERCs will not be able to adjust their own claims processing systems and a widespread lack of education in the medical community about physicians' new role in the process. “We need for you to truly consider a delay so we transition again in an orderly way as opposed to a rush to disorder,” Meuser said.

CMS' response: The agency is “listening” to that request.

Another attendee said it is inappropriate to require providers who are not medically trained to gather patient medical records from physicians, and then to hold providers responsible for deciding whether that documentation will support medical necessity.

As “laymen,” non-clinician suppliers are not qualified to make these medical evaluations, said Doug Harrison, president of The Scooter Store, New Braunfels, Texas. “Imagine the outcome if pharmacists first requested physician's chart notes from a patient, then analyzed those notes, and finally, refused to fill the prescription based upon his or her reading of the chart notes,” he said. “Neither the patients nor doctors would tolerate that outcome at a pharmacy, nor should they in the instance of the prescription of power mobility devices.”

But CMS' Dr. Richard Lawler responded that the agency has no intention of changing the requirement. “We're not asking the supplier to make a diagnostic information or to write the prescription,” he said. “But you do have to find between the time the prescription is made and it is supplied an ability to translate that prescription into a physical piece of equipment. That's your business that you're in.”